
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
    1.0390    0.0896    0.1098 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4969   -7.0390    0.2630 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0608   -1.7251   -1.7199 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5521   -0.3535   -1.2059 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5982   -2.9164   -0.9254 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3077   -3.8269   -1.2765 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8175   -4.7762   -0.2761 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5656   -0.7341    1.2101 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3003   -4.3467    0.9698 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9224   -6.1289   -0.5608 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8994   -5.2559    1.8379 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9899   -6.5753    1.4328 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  8  1  0
  2 10  2  0
  2 12  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  9  2  0
  7 10  1  0
  9 11  1  0
 11 12  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB05855

>  <COMMON_NAME>  (1) 
Rivanicline

>  <CAS_NUMBER>  (1) 
15585-43-0

>  <UNII>  (1) 
6H35LF645A

>  <SYNONYMS>  (1) 
(3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine; (E)-metanicotine; (E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine; N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine; Rivanicline; trans-metanicotine

$$$$
